Effects of age on parathyroid hormone signaling in human marrow stromal cells

Aging Cell

Volumn 10, Issue 5, 2011, Pages 780-788

  Zhou, Shuanhu ^a   Bueno, Ericka M ^a   Kim, Sung Won ^a   Amato, Ilaria ^a   Shen, Longxiang ^a   Hahne, Jochen ^a   Bleiberg, Ilan ^a   Morley, Paul ^b   Glowacki, Julie ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Zelos Therapeutics Inc   (United States)

Author keywords

catenin; Age; CREB; Differentiation; Human marrow stromal cells; Osteoblast; Parathyroid hormone; Proliferation; Signaling

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PARATHYROID HORMONE; PARATHYROID HORMONE DERIVATIVE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-31][27 LEUCINE] AMIDE 22,26 AMIDE; PARATHYROID HORMONE[1-34];

AGING; ARTICLE; BONE AGE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SKELETON; STROMA CELL;

ADULT; AGE FACTORS; AGED; AGING; ALKALINE PHOSPHATASE; BETA CATENIN; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEXAMETHASONE; ELECTROPORATION; FEMALE; HUMANS; ISOQUINOLINES; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOBLASTS; PARATHYROID HORMONE; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STROMAL CELLS; SULFONAMIDES; TRANSFECTION;

EID: 80955179995     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2011.00717.x     Document Type: Article

References (71)

1. Abdallah BM, Kassem M (2009) The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J. Cell. Physiol. 218, 9-12.
2. Abou-Samra AB, Jüppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV (1992) Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc. Natl. Acad. Sci. U. S. A. 89, 2732-2736.
3. Alves H, Munoz-Najar U, de Wit J, Renard AJ, Hoeijmakers JH, Sedivy JM, van Blitterswijk C, de Boer J (2009) A link between the accumulation of DNA damage and loss of multipotency of human mesenchymal stromal cells. J. Cell Mol. Med. 14, 2729-2738.
4. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M, Li JZ, Helm GA, Gazit D, Gazit Z (2006) Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 12, 877-889.
5. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl Acad. Sci. USA 102, 3324-3329.
6. Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, Lane TF, Krishnan V, Hankenson KD, MacDougald OA (2007) Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J. Bone Miner. Res. 22, 1924-1932.
7. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP (2002) Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J. Bone Miner. Res. 17, 1570-1578.
8. Bodine PV, Komm BS (2006) Wnt signaling and osteoblastogenesis. Rev. Endocr. Metab. Disord. 7, 33-39.
9. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521.
10. Canalis E, Centrella M, Burch W, McCarthy TL (1989) Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J. Clin. Invest. 83, 60-65.
11. Cole JA (1999) Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells. Endocrinology 140, 5771-5779.
12. Compston JE (2007) Skeletal actions of intermittent parathyroid hormone: effects on bone remodeling and structure. Bone 40, 1447-1452.
13. Deal C (2009) Potential new drug targets for osteoporosis. Nat. Clin. Pract. Rheumatol. 5, 20-27.
14. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J. Bone Miner. Res. 14, 1115-1122.
15. Donahue HJ, Zhou Z, Li Z, McCauley LK (1997) Age-related decreases in stimulatory G protein-coupled adenylate cyclase activity in osteoblastic cells. Am. J. Physiol. 273, E776-E781.
16. Egrise D, Martin D, Vienne A, Neve P, Schoutens A (1992) The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 13, 355-361.
17. Elis S, Courtland HW, Wu Y, Sun H, Rosen CJ, Yakar S (2010) Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. J. Bone Miner. Res. 25, 2051-2058.
18. Fehrer C, Lepperdinger G (2005) Mesenchymal stem cell aging. Exp. Gerontol. 40, 926-930.
19. Geng S, Zhou S, Glowacki J (2010) Age-related declines in expression of CYP27B1 and in osteoblast differentiation in human MSCs. J. Bone Miner. Res. 25S, 107.
20. Gentili C, Picotto G, Morelli S, Boland R, Russo de Boland A (2003) Effect of ageing in the early biochemical signals elicited by PTH in intestinal cells. Biochim. Biophys. Acta 1593, 169-178.
21. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523.
22. Gordeladze JO, Drevon CA, Syversen U, Reseland JE (2002) Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J. Cellular Biochem. 85, 825-836.
23. Gregory CA, Gunn WG, Peister A, Prockop DJ (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77-84.
24. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, Galvin RJ, Kuhstoss SA, Thomas CC, Schipani E, Baron R, Bringhurst FR, Kronenberg HM (2010) Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 11, 161-171.
25. Haramoto N, Kawane T, Horiuchi N (2007) Upregulation of PTH receptor mRNA expression by dexamethasone in UMR-106 osteoblast-like cells. Oral Dis. 13, 23-31.
26. Hocevar BA, Mou F, Rennolds JL, Morris SM, Cooper JA, Howe PH (2003) Regulation of Wnt signaling pathway by disabled-2 (Dab2). EMBO J. 22, 3084-3094.
27. Jeyapalan JC, Sedivy JM (2008) Cellular senescence and organismal aging. Mech. Ageing Dev. 129, 467-474.
28. Jilka RL, Almeida M, Ambrogini E, Han L, Roberson PK, Weinstein RS, Manolagas SC (2010) Decreased oxidative stress and greater bone anabolism in the aged, as compared to the young, murine skeleton by parathyroid hormone. Aging Cell 9, 851-867.
29. Jouishomme H, Whitfield JF, Gagnon L, Maclean S, Isaacs R, Chakravarthy B, Durkin J, Neugebauer W, Willick G, Rixon RH (1994) Further definition of the protein kinase C activation domain of the parathyroid hormone. J. Bone Miner. Res. 9, 943-949.
30. Kousteni S, Bilezikian JP (2008) The cell biology of parathyroid hormone in osteoblasts. Curr. Osteoporos. Rep. 6, 72-76.
31. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG (1999) Bone marrow stromal cells: characterization and clinical application. Crit. Rev. Oral Biol. Med. 10, 165-181.
32. Kulkarni NH, Halladay DL, Miles RR, Gilbert LM, Frolik CA, Galvin RJ, Martin TJ, Gillespie MT, Onyia JE (2005) Effects of parathyroid hormone on Wnt signaling pathway in bone. J. Cell. Biochem. 95, 1178-1190.
33. Lane NE, Silverman SL (2010) Anabolic therapies. Curr. Osteoporos. Rep. 8, 23-27.
34. Lee SK, Lorenzo JA (2002) Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures. Bone 31, 252-259.
35. Li X, Liu H, Qin L, Tamasi J, Bergenstock M, Shapses S, Feyen JH, Notterman DA, Partridge NC (2007) Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J. Biol. Chem. 282, 33086-33097.
36. Ling L, Nurcombe V, Cool SM (2009) Wnt signaling controls the fate of mesenchymal stem cells. Gene 433, 1-7.
37. Linkhart TA, Mohan S (1989) PTH stimulated the release of IGF-I and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125, 1484-1491.
38. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11-19.
39. Locklin RM, Khosla S, Turner RT, Riggs BL (2003) Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J. Cell. Biochem. 89, 180-190.
40. Lossdörfer S, Götz W, Rath-Deschner B, Jäger A (2006) Parathyroid hormone(1-34) mediates proliferative and apoptotic signaling in human periodontal ligament cells in vitro via protein kinase C-dependent and protein kinase A-dependent pathways. Cell Tissue Res. 325, 469-479.
41. McCarthy TL, Centrella M, Canalis E (1989) PTH enhances the transcript and polypeptide levels of IGF-I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124, 1247-1253.
42. Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J. Cell. Biochem. 82, 583-590.
43. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434-1441.
44. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE (1999) Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J. Bone Miner. Metab. 17, 171-177.
45. Nuttall ME, Gimble JM (2000) Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone 27, 177-184.
46. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
47. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74.
48. Qin L, Raggat LJ, Partridge NC (2004) Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol. Metab. 15, 60-65.
49. Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, Friedman PA (2010) Parathyroid hormone receptor directly interacts with dishevelled to regulate β-Catenin signaling and osteoclastogenesis. J. Biol. Chem. 285, 14756-14763.
50. Russo de Boland A (2004) Age-related changes in the response of intestinal cells to PTH. Mech. Ageing Dev. 125, 877-888.
51. Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A (2005) High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol. Oncol. 96, 355-361.
52. Sethe S, Scutt A, Stolzing A (2006) Aging of mesenchymal stem cells. Ageing Res. Rev. 5, 91-116.
53. Shen L, Zhou S, Glowacki J (2009) Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J. Cell. Biochem. 106, 337-343.
54. Suzuki A, Ozono K, Kubota T, Kondou H, Tachikawa K, Michigami T (2008) PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3β in osteoblastic Saos-2 cells. J. Cell. Biochem. 104, 304-317.
55. Swarthout JT, Doggett TA, Lemker JL, Partridge NC (2001) Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J. Biol. Chem. 276, 7586-7592.
56. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC (2002) Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282, 1-17.
57. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K (2006) Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147, 2583-2590.
58. Wan M, Yang C, Li J, Wu X, Yuan H, Ma H, He X, Nie S, Chang C, Cao X (2008) Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 22, 2968-2979.
59. Wang Y, Nishida S, Boudignon BM, Burghardt A, Elalieh HZ, Hamilton MM, Majumdar S, Halloran BP, Clemens TL, Bikle DD (2007) IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J. Bone Miner. Res. 22, 1329-1337.
60. Watson P, Lazowski D, Han V, Fraher L, Steer B, Hodsman A (1995) Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16, 357-365.
61. Weinstein RS, Jilka RL, Almeida M, Roberson PK, Manolagas SC (2010) Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151, 2641-2649.
62. Whitfield JF (2006) Osteoporosis-treating parathyroid hormone peptides: what are they? What do they do? How might they do it? Curr. Opin. Investig. Drugs 7, 349-359.
63. Whitfield JF, Isaacs R, MacLean S, Morley P, Barbier JR, Willick GE (1999) Stimulation of membrane-associated protein kinase-C activity in spleen lymphocytes by hPTH-(1-31)NH2, its lactam derivative, [Leu27]-cyclo(Glu22-Lys26)-hPTH-(1-31)NH2, and hPTH-(1-30)NH2. Cell. Signal. 11, 159-164.
64. Winn SR, Randolph G, Uludag H, Wong SC, Hair GA, Hollinger JO (1999) Establishing an immortalized human osteoprecursor cell line: OPC1. J. Bone Miner. Res. 14, 1721-1733.
65. Wong MM, Rao LG, Ly H, Hamilton L, Ish-Shalom S, Sturtridge W, Tong J, McBroom R, Josse RG, Murray TM (1994) In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporos. Int. 4, 21-31.
66. Yakar S, Bouxsein ML, Canalis E, Sun H, Glatt V, Gundberg C, Cohen P, Hwang D, Boisclair Y, Leroith D, Rosen CJ (2006) The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol. 189, 289-299.
67. Zhou S (2011) TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J. Cell. Biochem. 112, 1651-1660.
68. Zhou S, Eid K, Glowacki J (2004) Cooperation between TGF-β and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J. Bone Miner. Res. 19, 463-470.
69. Zhou S, Lechpammer S, Greenberger J, Glowacki J (2005) Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires TGFβ/Smad3 signaling. J. Biol. Chem. 280, 22688-22696.
70. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, LeBoff MS, Glowacki J (2008) Age-related intrinsic changes in human bone marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7, 335-343.
71. Zhou S, LeBoff MS, Glowacki J (2010) Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology 151, 14-22.